Researchers warn that the side effects of Nexium, Prilosec and similar heartburn drugs can interfere with certain cancer medications, resulting in lower survival rates for women with advanced breast cancer.
Some patient deaths have been linked to a clinical trial using a combination of Tecentriq and Avastin to prevent the return of liver cancer.
The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.
A case report warns of potentially extreme and deadly skin reactions linked to use of the cancer drug Tagrisso.
The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.
Teva has recently shut down a California manufacturing facility after recalling 2.5 million vials of unidentified drugs which may have had mold contamination.
A new study appears to identify factors which increase the risk of peripheral neuropathy linked to the use of some cancer drugs.
A new study reveals a link between some ovarian cancer drugs and an increased risk of blood cancers, like leukemia.
Some doctors warn the cancer drug Imbruvica appears to have toxic side effects which can result in heart rhythm problems and death.
The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.
